Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3709621rdf:typepubmed:Citationlld:pubmed
pubmed-article:3709621lifeskim:mentionsumls-concept:C0038527lld:lifeskim
pubmed-article:3709621lifeskim:mentionsumls-concept:C0022026lld:lifeskim
pubmed-article:3709621lifeskim:mentionsumls-concept:C0031507lld:lifeskim
pubmed-article:3709621lifeskim:mentionsumls-concept:C0679782lld:lifeskim
pubmed-article:3709621lifeskim:mentionsumls-concept:C1979874lld:lifeskim
pubmed-article:3709621lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:3709621lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:3709621pubmed:issue6lld:pubmed
pubmed-article:3709621pubmed:dateCreated1986-7-24lld:pubmed
pubmed-article:3709621pubmed:abstractTextContrast examinations of the subarachnoid space are associated with side effects including convulsions. Attention has been given to the prophylactic use of anticonvulsants. We describe a simple oral regimen using the established anticonvulsant phenytoin that can be administered to short-stay patients and that achieves effective serum and CSF concentrations. A preliminary account of this work was presented to the British Pharmacological Society in January 1984 in London.lld:pubmed
pubmed-article:3709621pubmed:languageenglld:pubmed
pubmed-article:3709621pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3709621pubmed:citationSubsetIMlld:pubmed
pubmed-article:3709621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3709621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3709621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3709621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3709621pubmed:statusMEDLINElld:pubmed
pubmed-article:3709621pubmed:issn0031-6970lld:pubmed
pubmed-article:3709621pubmed:authorpubmed-author:CaseyMMlld:pubmed
pubmed-article:3709621pubmed:authorpubmed-author:TeasdaleEElld:pubmed
pubmed-article:3709621pubmed:authorpubmed-author:WhitingBBlld:pubmed
pubmed-article:3709621pubmed:authorpubmed-author:MacphersonPPlld:pubmed
pubmed-article:3709621pubmed:authorpubmed-author:KellyJ CJClld:pubmed
pubmed-article:3709621pubmed:authorpubmed-author:VoldJJlld:pubmed
pubmed-article:3709621pubmed:authorpubmed-author:de VaneP JPJlld:pubmed
pubmed-article:3709621pubmed:issnTypePrintlld:pubmed
pubmed-article:3709621pubmed:volume29lld:pubmed
pubmed-article:3709621pubmed:ownerNLMlld:pubmed
pubmed-article:3709621pubmed:authorsCompleteYlld:pubmed
pubmed-article:3709621pubmed:pagination747-9lld:pubmed
pubmed-article:3709621pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3709621pubmed:meshHeadingpubmed-meshheading:3709621-...lld:pubmed
pubmed-article:3709621pubmed:meshHeadingpubmed-meshheading:3709621-...lld:pubmed
pubmed-article:3709621pubmed:meshHeadingpubmed-meshheading:3709621-...lld:pubmed
pubmed-article:3709621pubmed:meshHeadingpubmed-meshheading:3709621-...lld:pubmed
pubmed-article:3709621pubmed:meshHeadingpubmed-meshheading:3709621-...lld:pubmed
pubmed-article:3709621pubmed:meshHeadingpubmed-meshheading:3709621-...lld:pubmed
pubmed-article:3709621pubmed:meshHeadingpubmed-meshheading:3709621-...lld:pubmed
pubmed-article:3709621pubmed:meshHeadingpubmed-meshheading:3709621-...lld:pubmed
pubmed-article:3709621pubmed:meshHeadingpubmed-meshheading:3709621-...lld:pubmed
pubmed-article:3709621pubmed:year1986lld:pubmed
pubmed-article:3709621pubmed:articleTitleThe prophylactic use of phenytoin during iopamidol contrast studies of the subarachnoid space.lld:pubmed
pubmed-article:3709621pubmed:publicationTypeJournal Articlelld:pubmed